Leef Brands (LEEEF) Shares Outstanding (Weighted Average) (2023 - 2026)
Leef Brands' (LEEEF) quarterly Shares Outstanding (Weighted Average) came in at $259.7 million in Q1 2026, up 48.66% year-on-year from $174.7 million in Q1 2025, and up 331.68% quarter-over-quarter from $60.2 million in Q4 2025.
Leef Brands (LEEEF) Shares Outstanding (Weighted Average) (2023 - 2026) Analysis & Trends
Leef Brands has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $259.7 million for Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $259.7 million, up 48.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $259.7 million (up 48.66% YoY), and the FY2025 annual result was $60.2 million, down 57.81% from the prior year.
- Shares Outstanding (Weighted Average) came in at $259.7 million for Q1 2026 at Leef Brands, up from $60.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $259.7 million in Q1 2026 to a low of $60.2 million in Q4 2025.
- The 4-year median for Shares Outstanding (Weighted Average) is $142.6 million (2024), against an average of $151.1 million.
- Across the five-year window, Shares Outstanding (Weighted Average) tumbled 57.81% in 2025 and jumped 48.66% in 2026, its largest moves.
- Leef Brands' Shares Outstanding (Weighted Average) stood at $118.4 million in 2023, then advanced by 20.45% to $142.6 million in 2024, then sank by 57.81% to $60.2 million in 2025, then jumped by 331.68% to $259.7 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $259.7 million (Q1 2026), $60.2 million (Q4 2025), and $174.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Leef Brands | - | - | 4.62 Mn | 259.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259.68 Mn |
| Dec 31, 2025 | 60.16 Mn |
| Mar 31, 2025 | 174.68 Mn |
| Dec 31, 2024 | 142.60 Mn |
| Dec 31, 2023 | 118.38 Mn |